choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Human Genome Sciences Hepatitis

Human Genome Sciences Hepatitis Newsletter
  • Human Genome Sciences Offers 12.5 Million Common Shares 01 Dec 2009 10:14 GMT

    … 1, 2009 (FinancialWire) &#8212; Human Genome Sciences, Inc. (NASDAQ: HGSI) has launched … ;p> <p>Human Genome Sciences is a commercially focused biopharmaceutical … development, including ZALBIN for chronic hepatitis C and BENLYSTA for systemic …

  • Human Genome Sciences To Offer 18 Million Common Shares 28 Jul 2009 09:15 GMT

    … , 2009 (FinancialWire) &#8212; Human Genome Sciences, Inc. (NASDAQ: HGSI) said it … p>Rockville, Maryland-based Human Genome Sciences is a commercially focused biopharmaceutical … , including Zalbin for chronic hepatitis C and Benlysta for systemic …

  • Want to Prevent Another Coronavirus Epidemic? 29 Jan 2020 21:28 GMT

    … for the treatment of HIV, hepatitis B and herpes viruses. The … biological threats.” BioShield works. At Human Genome Sciences we developed the drug Abthrax …

  • AIDS Researcher Robert R. Redfield Named to Lead the C.D.C. 21 Mar 2018 22:01 GMT

    … with H.I.V. and hepatitis C would help him “hit … underwriters have included Aventis, Gilead, Human Genome Sciences, Merck and Schering. Kathleen Kennedy …

  • Biologics Market Trends and Forecasts to 2027 05 Dec 2017 15:03 GMT

    … chronic disorders, including cancer, diabetes, hepatitis and autoimmune diseases such as … Hexal Hindustan Antibiotic Histogenics Hospira Human Genome Sciences Human Stem Cells Institute Hypermarcas …

Satisfied with the content?

Continue to create your account.